NIDCD Phase I/II Preliminary Clinical Trials in Communication Disorders (R01)

Post Date

July 16th 2008

Application Due Date

September 7th 2011

Funding Opportunity Number

PAR-08-204

CFDA Number(s)

93.173

Funding Instrument Type(s)

Grant

Funding Activity Categories

Health

Eligibility Categories

State Governments
County Governments
City or Township Governments
Special District Governments
Independent School Districts
Public and State Controlled Institutions of Higher Education
Federally Recognized Native American Tribal Governments
Public Housing Authorities or Indian Housing Authorities
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Funding

• Award Range:

  $None - $None

Grant Description

-Purpose. The NIDCD is committed to identifying effective interventions for the treatment or prevention of communication disorders by supporting robust, well-designed, and well-executed clinical trials.ÊBefore a full scale Phase III Definitive Clinical Trial (DCT) (PAR-08-205) can be undertaken, earlier stage Phase I/II Preliminary Clinical Trials (PCT) are often required.ÊThis FOA is specifically targeted towards supporting studies that will provide the preliminary data that are necessary to address core scientific, design, and clinical issues prior to the conduct of the Phase III DCT.ÊIt is intended that these PCTs will serve to optimize the design of the eventual Phase III DCT and NOT address the definitive clinical question with lower power. -Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) grant mechanism.ÊApplications involving multi-sites or with $500,000 or more in Direct Costs in any grant year may be converted to the U01 grant mechanism (cooperative agreement) at the time of the award indicating substantial NIDCD staff involvement. -Funds Available and Anticipated Number of Awards.ÊAwards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/pa-files/PAR-08-204.html